Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Colorcon
Daiichi Sankyo
Deloitte
Accenture
US Army
Fuji
Merck
Mallinckrodt
QuintilesIMS

Generated: December 11, 2017

DrugPatentWatch Database Preview

MITOSOL Drug Profile

« Back to Dashboard

Which patents cover Mitosol, and when can generic versions of Mitosol launch?

Mitosol is a drug marketed by Mobius Therap and is included in one NDA. There are five patents protecting this drug.

This drug has nine patent family members in five countries.

The generic ingredient in MITOSOL is mitomycin. There are seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the mitomycin profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Mobius TherapMITOSOLmitomycinFOR SOLUTION;TOPICAL022572-001Feb 7, 2012RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Mobius TherapMITOSOLmitomycinFOR SOLUTION;TOPICAL022572-001Feb 7, 2012RXYesYes► Subscribe► Subscribe► SubscribeYY► Subscribe
Mobius TherapMITOSOLmitomycinFOR SOLUTION;TOPICAL022572-001Feb 7, 2012RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Mobius TherapMITOSOLmitomycinFOR SOLUTION;TOPICAL022572-001Feb 7, 2012RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Mobius TherapMITOSOLmitomycinFOR SOLUTION;TOPICAL022572-001Feb 7, 2012RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Mobius TherapMITOSOLmitomycinFOR SOLUTION;TOPICAL022572-001Feb 7, 2012RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: MITOSOL

Country Document Number Estimated Expiration
Australia2007272514► Subscribe
Japan2014097399► Subscribe
World Intellectual Property Organization (WIPO)2008008802► Subscribe
Japan5670546► Subscribe
European Patent Office2046653► Subscribe
Japan5448071► Subscribe
Canada2659314► Subscribe
European Patent Office3175843► Subscribe
Japan2009543608► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Johnson and Johnson
Chinese Patent Office
Teva
Dow
Julphar
Argus Health
Farmers Insurance
Chubb
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot